Skip to Content
AP National Business

Halozyme Therapeutics: Q4 Earnings Snapshot

KION
By
Published 1:21 PM

SAN DIEGO (AP) — SAN DIEGO (AP) — Halozyme Therapeutics Inc. (HALO) on Tuesday reported fourth-quarter earnings of $57.7 million.

The San Diego-based company said it had profit of 42 cents per share. Earnings, adjusted for one-time gains and costs, came to 48 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 47 cents per share.

The biopharmaceutical company posted revenue of $181.5 million in the period, which did not meet Street forecasts. Six analysts surveyed by Zacks expected $186.1 million.

For the year, the company reported profit of $202.1 million, or $1.44 per share. Revenue was reported as $660.1 million.

Halozyme Therapeutics expects full-year earnings in the range of $2.50 to $2.65 per share, with revenue in the range of $815 million to $845 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HALO at https://www.zacks.com/ap/HALO

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KION 46 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content